A Phase I/IIa Clinical Trial to Evaluate Effect of IAP0971 in Patients With Advanced Malignant Tumors
Status:
Not yet recruiting
Trial end date:
2024-11-30
Target enrollment:
Participant gender:
Summary
This is a Phase I Clinical Trial to Evaluate the Safety, Tolerability and Preliminary
Effectiveness of IAP0971 in Patients with Advanced Malignant Tumors.